AI-generated summary
The authors report testing doxorubicin-loaded gold nanospheres that target EphB4 receptors on tumors, combined with near-infrared laser heating, in three EphB4-positive tumor models in vitro and in vivo. Compared with nontargeted nanoparticles or gold nanospheres alone, the targeted version was associated with significantly reduced tumor growth, and 6 of 8 treated mice had complete tumor regression. The study was conducted in cells and mice, so its relevance to humans is not established.
- Participants
- 8
- Who or what was studied
- Mice bearing three EphB4-positive tumors, plus in vitro cell experiments
- Limits stated in the abstract
- The abstract describes only cell and mouse experiments, with a small group of 8 treated mice, and gives no human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on aacrjournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Near-infrared, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.